Identifying specific matrix metalloproteinase-2-inhibiting peptides through phage display-based subtractive screening

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Matrix metalloproteinases (MMPs), including gelatinases A and B, are crucial in cancer progression and metastasis due to their role in basal membrane degradation.
• Targeting gelatinases is essential for effective cancer treatment strategies.
• Specific peptide inhibitors offer a promising therapeutic approach for blocking gelatinase activity.

Purpose of the Study:

• To identify specific peptide inhibitors for gelatinase A (MMP-2) using subtractive biopanning.
• To evaluate the efficacy of identified peptides in inhibiting MMP-2 activity.
• To assess the potential therapeutic application of these peptides in cancer treatment.

Main Methods:

• Subtractive biopanning employing a 12-mer peptide library against MMP-2.
• Zymogram analysis to quantify MMP-2 inhibition by selected peptides.
• In vitro wound healing assays using human umbilical vein endothelial cells to evaluate peptide effects.

Main Results:

• Seventeen unique peptide sequences were identified through subtractive panning.
• Four peptides demonstrated significant MMP-2 inhibition (≥65%) via zymogram analysis.
• Two synthesized peptides, AOMP12 and AOMP29, inhibited endothelial cell wound healing by 40%.

Conclusions:

• The identified peptides, particularly AOMP12 and AOMP29, are potential candidates for MMP-2 targeted cancer therapy.
• Subtractive biopanning is an effective method for discovering selective MMP-2 inhibitory peptides.
• These findings contribute to the development of novel anti-cancer agents targeting MMP-2.